Literature DB >> 26375169

The Half RR Rule: A Poor Rule of Thumb and Not a Risk Assessment Tool for QT Interval Prolongation.

Ingrid Berling1,2, Geoffrey K Isbister1,2.   

Abstract

OBJECTIVES: Measuring the QT interval on an electrocardiogram (ECG) is integral to risk assessment of Torsade de Pointes (TdP). This study aimed to investigate the accuracy of the 1/2 RR rule as a risk assessment tool for drug-induced TdP, comparing it to the QT nomogram, Bazett's corrected QT (QTcB), and Fridericia's corrected QT (QTcF).
METHODS: The authors calculated sensitivity and specificity of the 1/2 RR rule using a published data set of 129 cases of drug-induced TdP and 316 controls (noncardiotoxic overdoses), compared to the QT nomogram, QTcB > 500 msec and QTcF > 500 msec. To further determine the value of the 1/2 RR rule, its observed positive, and negative agreement were calculated when compared to the QT nomogram for determining an abnormal QT in eight samples of different drugs in overdose.
RESULTS: The sensitivity and specificity of the 1/2 RR rule were 88% (95% confidence interval [CI] = 80% to 93%) and 53% (95% CI = 47% to 58%), respectively, compared to the QT nomogram (sensitivity = 97%, 95% CI = 92% to 99%; specificity = 99%, 95% CI = 97% to 100%). It was also less sensitive than QTcB > 500 msec and had a lower specificity than QTcB > 500 msec and QTcF > 500 msec. In drug overdose patients, the 1/2 RR rule had poor observed agreement averaging 41%, which was mainly due to poor positive agreement, except for amisulpride where there was good agreement.
CONCLUSIONS: The 1/2 RR rule was not as sensitive as the QT nomogram or QTcB > 500 msec for drug-induced TdP. It had poor positive agreement in almost all overdose patients, resulting in over half of patients receiving unnecessary cardiac monitoring and repeat ECGs.
© 2015 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Year:  2015        PMID: 26375169     DOI: 10.1111/acem.12752

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  4 in total

Review 1.  Measurement and Management of QT Interval Prolongation for General Physicians.

Authors:  Praveen Indraratna; Daniel Tardo; Madeline Delves; Richard Szirt; Ben Ng
Journal:  J Gen Intern Med       Date:  2019-10-25       Impact factor: 5.128

Review 2.  Risk assessment tools for QT prolonging pharmacotherapy in older adults: a systematic review.

Authors:  Simone Skullbacka; Marja Airaksinen; Juha Puustinen; Terhi Toivo
Journal:  Eur J Clin Pharmacol       Date:  2022-02-14       Impact factor: 2.953

3.  QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings.

Authors:  Geoffrey K Isbister; Amanda L Brown; Anthony Gill; Alexander J Scott; Leonie Calver; Adrian J Dunlop
Journal:  Br J Clin Pharmacol       Date:  2017-06-14       Impact factor: 4.335

4.  A Practical Method for QTc Interval Measurement.

Authors:  Nestor R De Oliveira Neto; William Santos De Oliveira; Guilherme D Campos Pinto; Eric Santos R De Oliveira; Maria das Neves D Da Silveira Barros
Journal:  Cureus       Date:  2020-12-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.